Further bioinformatics analysis of the TCGA data set revealed that >32% human HCC patients had EZH2 gene copy number gain/amplification, whereas the expression level of EZH2 was positively correlated with its copy number values (Fig. 2d, e). This evidence concerns the gene EZH2 and hepatocellular carcinoma.